Form D · Pharmaceuticals
Occam Sciences, Inc.
New Haven, CT · CIK 0001533185
Offering snapshot reported Oct 21, 2011 · SEC filing
- Reported sold
- $300K Offering amount: $300K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2011 | Initial | $300,020 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167647
Source: Form D, filed Oct 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Bettigole | Director, Executive |
| Brian Dixon | Director |
| Merton G. Gollaher | Executive |
| Joseph Pont | Director |
| John Warner | Director |
| David Whittaker | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
C/O Elm Street Ventures 33 Whitney Street
New Haven, CT, 06510
New Haven, CT, 06510